INTERDISCIPLINARY TRAINING IN CHILDHOOD CANCER RESEARCH

儿科肿瘤学在多学科领域具有领导地位 病人护理多机构跨学科临床 研究，以及基础和临床研究的整合。 在这方面继续取得进展越来越具有挑战性， 临床和生物学研究的复杂性增加， 合作学科变得更加专业化。 我们必须 培训对儿童癌症感兴趣的调查人员， 在临床和生物学研究方面的专业。 司 费城儿童医院（CHOP）的肿瘤科有很多 广受欢迎的，董事会认证的三年制儿科项目 血液肿瘤学研究员培训，50%的研究员 用于临床或基础研究的时间。 这个程序有 自1985年以来，培训了16名研究员，其中14名是全日制学术人员， 从事临床和/或实验室研究的职位。 该司 及其在CHOP、宾夕法尼亚大学和 Wistar研究所在临床和基础研究领域具有良好的领导记录， 科学研究 我们在这里建议培训选定的儿科肿瘤学 通过增加足够的支持，基础和临床研究的研究员 时间给他们的奖学金，以便完成这两个领域的项目。 我们亦建议为住院医生和研究员提供研究训练 来自神经病学、放射肿瘤学、外科学和其他专业， 目前很少或没有延长的机会进行癌症 research. 所提供的支持将使我们能够减少财政负担， 现在阻止许多受训者获得高级 研究训练。 通过这个项目，我们将培养下一个 一代临床癌症研究人员，他们的工作是把基本的 科学对临床问题的影响将促进抗癌的进展 在未来的几十年里，在所有年龄组中。

Pediatric oncology has a record of leadership in multidisciplinary patient care, multi-institutional. and interdisciplinary clinical research, and the integration of basic and clinical investigation. Continued progress in this direction is becoming more challenging, as the sophistication of clinical and biological research increases, and as cooperating disciplines become more specialized. It is essential that we train investigators interested in childhood cancer from different medical specialties in both clinical and biological research. The Division of Oncology of The Children's Hospital of Philadelphia (CHOP) has a much sought-after, board-certified three-year program of pediatric hematology-oncology fellowship training, with 50% percent of the fellows' time spent in either clinical or basic research. This program has trained 16 fellows since 1985, of whom 14 are in full-time academic positions conducting clinical and/or laboratory research. The Division and its affiliates at CHOP, the University of Pennsylvania, and the Wistar Institute have a strong record of leadership in clinical and basic science research. We propose here to train selected pediatric oncology fellows in both basic and clinical research, by adding enough supported time to their fellowships to allow completion of projects in both areas. We also propose to provide research training to residents and fellows from neurology, radiation oncology, surgery, and other specialties, who currently have few or no extended opportunities to conduct cancer research. The support provided would permit us to reduce the financial deterrents which now prevent many trainees from obtaining advanced research training. Through this program, we will train the next generation of clinical cancer researchers, whose work in bringing basic science to bear on clinical problems will advance progress against cancer in all age groups in the decades ahead.